Moderna, Inc. - Common Stock (OQ:MRNA)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for MRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -222,365  
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -18,635  
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Common Stock S - Open market or private sale -241,000 $51.13
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,635 $12.21
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 222,365 $14.22
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -42,570  
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -82,474  
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Common Stock S - Open market or private sale -125,044 $66.54
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 82,474 $12.21
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 42,570 $14.22
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -222,365  
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -18,635  
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Common Stock S - Open market or private sale -241,000 $51.13
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,635 $12.21
May 28/20 May 27/20 Kim Lorence H. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 222,365 $14.22
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -42,570  
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -82,474  
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Common Stock S - Open market or private sale -125,044 $66.54
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 82,474 $12.21
May 28/20 May 26/20 Zaks Tal Zvi Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 42,570 $14.22
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MRNA

Competitors

Competitors with Recent Insider Filings
No competitors with recent insider filings.